Findings from Shanxi Medical University in Alzheimer Disease Reported (A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease)

Medicine

Press/Media: Research

PeriodNov 8 2022

Media coverage

1

Media coverage

  • TitleFindings from Shanxi Medical University in Alzheimer Disease Reported (A GLP-1/GIP Dual Receptor Agonist DA4-JC Effectively Attenuates Cognitive Impairment and Pathology in the APP/PS1/Tau Model of Alzheimer's Disease)
    Media name/outletPain & Central Nervous System Daily News
    Country/TerritoryUnited States
    Date11/8/22
    PersonsJun Wang
View all 1
View less